基于体检人群的非酒精性脂肪肝筛查工具的建立
Construction of a NAFLD screening tool based on health examination subjects

DOI: 10.6040/j.issn.1671-7554.0.2016.1275

Keywords: 非酒精性脂肪肝,筛查,体检人群,脂肪肝指数,
Nonalcoholic fatty liver disease,Health examination clients,Fatty liver index,Screening

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Machado MV, Cortez-Pinto H. Non-alcoholic fatty liver disease: what the clinician needs to know[J]. World J Gastroenterol, 2014, 20(36): 12956-12980.
[2]	Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation[J]. Am J Gastroenterol, 2007, 102(12): 2708-2715.
[3]	Duman DG, Celikel C, Tuney D, et al. Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?[J]. Dig Dis Sci, 2006, 51(2): 346-351.
[4]	Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease[J]. Dig Liver Dis, 2010, 42(7): 503-508.
[5]	Park YJ, Lim JH, Kwon ER, et al. Development and validation of a simple index system to predict nonalcoholic fatty liver disease[J]. Korean J Hepatol, 2011, 17(1): 19-26.
[6]	Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population[J]. BMC Gastroenterol, 2006, 6(1): 33. doi: 10.1186/1471-230X-6-33.
[7]	Zhang T, Zhang C, Zhang Y, et al. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study[J]. Atherosclerosis, 2015, 240(1): 144-148.
[8]	Wong VW, Chu WC, Wong GL, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography[J]. Gut, 2012, 61(3): 409-415.
[9]	Lee SW, Park SH, Kim KW, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index[J]. Radiology, 2007, 244(2): 479-485.
[10]	Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease[J]. Atherosclerosis, 2015, 239(1): 192-202.
[11]	Fan JG, Jia JD, Li YM, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010[J]. Journal of Digestive Diseases, 2011, 12(1): 38-44.
[12]	Farrell GC, Wong VW, Chitturi S. NAFLD in Asia-as common and important as in the West[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(5): 307-318.
[13]	Park HE, Kwak MS, Kim D, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification development: a longitudinal study[J]. J Clin Endocrinol Metab, 2016, 101(8): 3134-3143.
[14]	Kim BJ, Kim NH, Kim BS, et al. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals[J]. Cardiology, 2012, 123(1): 54-61.
[15]	Wong VW, Wong GL, Yip GW, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease[J]. Gut, 2011, 60(12): 1721-1727.
[16]	Permutt Z, Le TA, Peterson MR, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease-MRI accurately quantifies hepatic steatosis in NAFLD[J]. Aliment Pharmacol Ther, 2012, 36(1): 22-29.
[17]	中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007,35(5):390-419. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults(no abstract)[J]. Chinese Journal of Cardiology. 2007, 35(5): 390-419.
[18]	中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 中国肝脏病杂志, 2010,18(3):163-166. The Chinese National Workshop on Fatty Liver and Alcohol and Liver Disease for the Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition[J]. Chinese Journal of Hepatology, 2010, 18(3): 163-166.
[19]	Nalbantoglu IL, Brunt EM. Role of liver biopsy in nonalcoholic fatty liver disease[J]. World J Gastroenterol, 2014, 20(27): 9026-9037.
[20]	Hamaguchi M, Takeda N, Kojima T, et al. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome[J]. World J Gastroenterol, 2012, 18(13): 1508-1516.
[21]	Asrih M, Jornayvaz FR. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?[J]. Mol Cell Endocrinol, 2015, 418: 55-65. doi:10.1016/j.mce.2015.02.018.
[22]	Puri P, Baillie RA, Wiest MM, et al. A lipidomic analysis of nonalcoholic fatty liver disease[J]. Hepatology, 2007, 46(4): 1081-1090.
[23]	Stepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population[J]. Clin Gastroenterol Hepatol, 2012, 10(6): 646-650.
[24]	Reeder SB, Cruite I, Hamilton G, et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy[J]. J Magn Reson Imaging, 2011, 34(4): 729-749.
[25]	Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(11): 666-675.

Full-Text